Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Trautec / 创健医疗

Request full access

NEEQ recombinant-collagen biomaterials for medical aesthetics

Changzhou, ChinaFounded 2015Robotics

About Trautec / 创健医疗

Changzhou NEEQ recombinant-collagen biomaterials OEM (Trautec / 创健医疗; NEEQ 873474) — synthetic-biology collagen raw materials and medical-aesthetics / regenerative devices spanning China clinic and beauty-ingredient channels. Mid-size China medical-aesthetics leftover beyond Pack 43 Imeik / Cutia, Giant Biogene this pack, and Jinbo employees-only thinner.

Source: Dealroom company data

At a glance

Status
Operational
Employees
9
Open positions
None listed
Dealroom signal
33.3/100
Industry
Robotics
Sector
Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Sep 2023 $28M $110M Chunchuang Investment · Mingfeng Capital · CITIC Securities · L Catterton ↗
SERIES AOther financing Aug 2022 $28M $110M Beijing Huafang Investment · Shiseido · CDH Investments · Holley Group ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Trautec / 创健医疗 website traffic

Latest recorded traffic for Trautec / 创健医疗 is 80 monthly website visits, down 90% over the last three months. Trautec / 创健医疗's team declined 18.2% over the past year.

Latest monthly visits80 3-month web change-90% 1-year team growth-18.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Trautec / 创健医疗 in the Changzhou ecosystem

Live from Dealroom

The Trautec / 创健医疗 office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

  • Shiseido
  • Beijing Huafang Investment
  • CDH Investments
  • Holley Group
  • CITIC Securities
  • L Catterton
  • Chunchuang Investment
  • Mingfeng Capital
Employees 9 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China60%
🇺🇸 United States40%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Trautec / 创健医疗 on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Trautec / 创健医疗’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.